AI in Neurology: What Tools Are Emerging?
Jerome Lisk, MD, MBA, M.S., FAAN
Mark Mintz, MD
Diving into the Debate Surrounding Aducanumab for Alzheimer’s
Peter Whitehouse, MD, PhD
What to Know About Post-COVID-19 Neurological Syndrome
Tissa Wijeratne MD PhD FRACP FRCP FAAN
Social Media: A Friend or Foe for Healthcare Professionals?
Hector O. Chapa, MD, FACOG
Mikaela Rush, MD FACOG
Discussing Drug Diversion: An Exploration of Impact & Prevention Through Smart Data
Charles Turck, PharmD, BCPS, BCCCP
Michael LaFauci
Jeffrey Wahl
Deep Brain Stimulation in the OR: What Neurologists & Patients Can Expect
Jerrold L. Vitek, MD, PhD
Explore the World with a Career in Locum Tenens
Jennifer Caudle, DO, FACOFP
Dalilah Restrepo, MD
Shedding Light on the Brain After COVID-19: Assessing the Spectrum of Neurological Risk
Andrew Wilner, MD, FACP, FAAN
Jennifer Frontera, MD
Expanding on the Neurologic Effects of COVID-19
The Future of Restoring Functionality in Stroke Survivors
David Weisman, MD
Mijail D Serruya MD,PhD
Investigating the Variants of the COVID-19 Virus
Ken Tyler, MD
High Price: How A Neuroscientist's Journey of Self-Discovery is Challenging Society's Perception on Drugs
Maurice Pickard, MD
Carl Hart, MD
Evaluation of Chronic Traumatic Encephalopathy in Football Players
The Biophysics of Minimizing Brain Damage After Hemorrhagic Stroke
Brian P. McDonough, MD, FAAFP
Annalisa Scimemi
Can Mentally Stimulating Activities Reduce the Risk of Mild Cognitive Impairment in Seniors?
Challenges and Solutions to Alzheimer's Research Funding Barriers
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.